Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Krista M. King"'
Autor:
Krista M King, Anas Younes
Publikováno v:
Expert Review of Anticancer Therapy. 1:177-186
Rituximab (Rituxan) was the first monoclonal antibody approved for cancer therapy and the first single-agent approved for therapy of lymphoma. When combined with CHOP, rituximab is the only drug that has been shown to improve survival of a subpopulat
Autor:
Todd W. Canada, Ginger Langley, Krista M. King, Kenneth V. I. Rolston, Gregory H. Botz, Gregory F. Pratt
Publikováno v:
Expert review of pharmacoeconomicsoutcomes research. 6(1)
Hospital care, physician and clinical services, and prescription drugs continue to drive healthcare expenditures across healthcare systems and nations. The critical-care setting, owing to the complexity and intensity of care, is a high user of the re
Publikováno v:
Expert review of pharmacoeconomicsoutcomes research. 2(3)
Healthcare costs in the USA continue to rise faster than the consumer price index. Nothing demonstrates this more vividly than the double-digit increases posted for the cost of the drug treatment of the oncology patient. A factor that will compound t
Autor:
Holly M. Holmes, Jessica P. Hwang, Rana Saab, Rebecca Arbuckle, Krista M. King, Jason M. Etchegaray, Joe Ensor, Carmen P. Escalante, Michael A. Kallen
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 18(10)
Due to high coexistence of comorbidity, cancer patients take many medications and are susceptible to negative consequences of polypharmacy. To avoid adverse events during care transitions, patients need to correctly communicate their medications. The
Publikováno v:
Dalton Transactions. 41:7959
Pincer complexes of the type [2,6-(R(2)PO)(2)C(6)H(3)]NiSC(6)H(4)Z (R = Ph and i-Pr; Z = p-OCH(3), p-CH(3), H, p-Cl, and p-CF(3)) have been synthesized from [2,6-(R(2)PO)(2)C(6)H(3)]NiCl and sodium arylthiolate. X-ray structure determinations of thes